霍乱弧菌感染无菌小鼠模型的建立。
Development of a germfree mouse model of Vibrio cholerae infection.
作者信息
Butterton J R, Ryan E T, Shahin R A, Calderwood S B
机构信息
Infectious Disease Unit, Massachusetts General Hospital, Boston 02114, USA.
出版信息
Infect Immun. 1996 Oct;64(10):4373-7. doi: 10.1128/iai.64.10.4373-4377.1996.
Abstract
A mouse model of Vibrio cholerae infection was successfully developed with germfree mice. Three- to four-week-old germfree mice were orally inoculated with strains of V. cholerae to be tested and then moved to normal housing after inoculation. Stool culture, measurement of serum vibriocidal antibody titers, and determination of immune responses to the cholera toxin B subunit demonstrated that germfree mice are readily colonized by V cholerae and develop systemic and mucosal immune responses to antigens expressed by these organisms. Immune responses to the B subunit of Shiga toxin 1, which was expressed from a V. cholerae vaccine vector, were less pronounced. This model should be valuable for studying immune responses to V. cholerae infection and immunization, including responses to heterologous antigens expressed by cholera vector strains.
摘要
利用无菌小鼠成功建立了霍乱弧菌感染的小鼠模型。将3至4周龄的无菌小鼠经口接种待测试的霍乱弧菌菌株，接种后转移至正常饲养环境。粪便培养、血清杀弧菌抗体滴度测定以及对霍乱毒素B亚单位的免疫反应测定表明，无菌小鼠很容易被霍乱弧菌定殖，并对这些细菌表达的抗原产生全身和黏膜免疫反应。对由霍乱弧菌疫苗载体表达的志贺毒素1 B亚单位的免疫反应则不太明显。该模型对于研究霍乱弧菌感染和免疫的免疫反应，包括对霍乱载体菌株表达的异源抗原的反应应该是有价值的。
相似文献
1
Development of a germfree mouse model of Vibrio cholerae infection.霍乱弧菌感染无菌小鼠模型的建立。
Infect Immun. 1996 Oct;64(10):4373-7. doi: 10.1128/iai.64.10.4373-4377.1996.
2
Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains.霍乱弧菌疫苗菌株中志贺毒素1 B亚基与肠出血性大肠杆菌EaeA的共表达。
Infect Immun. 1997 Jun;65(6):2127-35. doi: 10.1128/iai.65.6.2127-2135.1997.
3
Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice.用表达与霍乱毒素B亚基融合的富含丝氨酸的溶组织内阿米巴蛋白的十二肽重复序列的霍乱弧菌减毒疫苗株进行口服免疫，可在小鼠体内诱导全身性和粘膜性抗阿米巴及抗霍乱弧菌抗体反应。
Infect Immun. 1997 Aug;65(8):3118-25. doi: 10.1128/iai.65.8.3118-3125.1997.
4
Long-Term Kinetics of Serological Antibodies against Following a Clinical Cholera Case: A Systematic Review and Meta-Analysis.临床霍乱病例后血清抗体针对 的长期动力学：系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Jun 10;19(12):7141. doi: 10.3390/ijerph19127141.
5
Emerging antibiotic resistance in Vibrio cholerae: a study of cholera prevalence and resistance patterns in Zambia's Copperbelt Province.霍乱弧菌新出现的抗生素耐药性：赞比亚铜带省霍乱流行情况及耐药模式研究
BMC Infect Dis. 2025 Jul 1;25(1):879. doi: 10.1186/s12879-025-11259-w.
6
Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains.优化无菌小鼠模型以用于霍乱弧菌口服疫苗和载体菌株的体内评估。
Infect Immun. 2000 Feb;68(2):977-81. doi: 10.1128/IAI.68.2.977-981.2000.
7
Rapid tests as a practical alternative to slide agglutination for the confirmation of O1.快速检测作为替代玻片凝集试验用于确认O1的实用方法。
J Clin Microbiol. 2025 Aug 13;63(8):e0043325. doi: 10.1128/jcm.00433-25. Epub 2025 Jul 17.
8
Genetic approach toward linkage of Iran 2012-2016 cholera outbreaks with 7th pandemic Vibrio cholerae.遗传方法分析伊朗 2012-2016 年霍乱疫情与第七次霍乱大流行弧菌的关系。
BMC Microbiol. 2024 Jan 22;24(1):33. doi: 10.1186/s12866-024-03185-9.
9
Estimating the proportion of clinically suspected cholera cases that are true Vibrio cholerae infections: A systematic review and meta-analysis.估算临床疑似霍乱病例中真正的霍乱弧菌感染比例：系统评价和荟萃分析。
PLoS Med. 2023 Sep 14;20(9):e1004286. doi: 10.1371/journal.pmed.1004286. eCollection 2023 Sep.
10
In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae.大肠杆菌不耐热肠毒素突变体在霍乱弧菌疫苗株和载体株中的体内表达及免疫佐剂作用
Infect Immun. 1999 Apr;67(4):1694-701. doi: 10.1128/IAI.67.4.1694-1701.1999.
引用本文的文献
1
Intestinal colonization against : host and microbial resistance mechanisms.肠道定植防御：宿主和微生物抗性机制
AIMS Microbiol. 2023 Apr 13;9(2):346-374. doi: 10.3934/microbiol.2023019. eCollection 2023.
2
Modulation of Host-Microbe Metabolism by Cholera Toxin.霍乱毒素对宿主-微生物代谢的调节。
Infect Immun. 2023 May 16;91(5):e0043522. doi: 10.1128/iai.00435-22. Epub 2023 Apr 6.
3
A dysbiotic gut microbiome suppresses antibody mediated-protection against .功能失调的肠道微生物群会抑制抗体介导的针对……的保护作用。
iScience. 2021 Nov 14;24(12):103443. doi: 10.1016/j.isci.2021.103443. eCollection 2021 Dec 17.
4
Friends or Foes-Microbial Interactions in Nature.朋友还是敌人——自然界中的微生物相互作用
Biology (Basel). 2021 Jun 2;10(6):496. doi: 10.3390/biology10060496.
5
Dissecting serotype-specific contributions to live oral cholera vaccine efficacy.解析血清型特异性对口服霍乱活疫苗效力的贡献。
Proc Natl Acad Sci U S A. 2021 Feb 16;118(7). doi: 10.1073/pnas.2018032118.
6
Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice.口服减毒霍乱活疫苗对链霉素处理小鼠的短暂肠道定植诱导保护性免疫应答。
J Bacteriol. 2020 Nov 19;202(24). doi: 10.1128/JB.00232-20.
7
Host-Microbe-Pathogen Interactions: A Review of Pathogenesis in .宿主-微生物-病原体相互作用：对 发病机制的综述。
Front Immunol. 2020 Jan 24;10:3128. doi: 10.3389/fimmu.2019.03128. eCollection 2019.
8
Oral immunization with a probiotic cholera vaccine induces broad protective immunity against Vibrio cholerae colonization and disease in mice.口服益生菌霍乱疫苗可诱导小鼠对霍乱弧菌定植和疾病产生广泛的保护免疫。
PLoS Negl Trop Dis. 2019 May 31;13(5):e0007417. doi: 10.1371/journal.pntd.0007417. eCollection 2019 May.
9
Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model.一种不含硫柳汞的二价口服霍乱灭活疫苗Euvichol在动物模型中的免疫原性。
Clin Exp Vaccine Res. 2018 Jul;7(2):104-110. doi: 10.7774/cevr.2018.7.2.104. Epub 2018 Jul 31.
10
The Significance of the Intestinal Microbiome for Vaccinology: From Correlations to Therapeutic Applications.肠道微生物组对疫苗学的意义：从相关性到治疗应用。
Drugs. 2018 Jul;78(11):1063-1072. doi: 10.1007/s40265-018-0941-3.
本文引用的文献
1
Use of the Vibrio cholerae irgA gene as a locus for insertion and expression of heterologous antigens in cholera vaccine strains.霍乱弧菌irgA基因作为霍乱疫苗菌株中异源抗原插入和表达位点的应用。
Vaccine. 1993 Oct;11(13):1327-35. doi: 10.1016/0264-410x(93)90103-5.
2
Emergence of a new cholera pandemic: molecular analysis of virulence determinants in Vibrio cholerae O139 and development of a live vaccine prototype.新型霍乱大流行的出现：霍乱弧菌O139毒力决定因素的分子分析及减毒活疫苗原型的研制
J Infect Dis. 1994 Aug;170(2):278-83. doi: 10.1093/infdis/170.2.278.
3
The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.霍乱弧菌O139血清群抗原包括O抗原荚膜和脂多糖毒力决定簇。
Proc Natl Acad Sci U S A. 1994 Nov 22;91(24):11388-92. doi: 10.1073/pnas.91.24.11388.
4
Heterologous antigen expression in Vibrio cholerae vector strains.霍乱弧菌载体菌株中的异源抗原表达。
Infect Immun. 1995 Jul;63(7):2689-96. doi: 10.1128/iai.63.7.2689-2696.1995.
5
Safety, immunogenicity, and efficacy of live attenuated Vibrio cholerae O139 vaccine prototype.
Lancet. 1995 Apr 15;345(8955):949-52. doi: 10.1016/s0140-6736(95)90698-3.
6
Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies.趋化作用在运动性细菌与肠黏膜结合中的作用：体内研究
Infect Immun. 1981 Oct;34(1):234-40. doi: 10.1128/iai.34.1.234-240.1981.
7
Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1.通过口服接种霍乱弧菌O1对成年兔进行成功定殖和免疫。
Infect Immun. 1983 Aug;41(2):735-41. doi: 10.1128/iai.41.2.735-741.1983.
8
Progressive changes of Vibrio serotypes in germ-free mice infected with Vibrio cholerae.感染霍乱弧菌的无菌小鼠中弧菌血清型的渐进性变化。
J Bacteriol. 1969 Sep;99(3):688-95. doi: 10.1128/jb.99.3.688-695.1969.
9
Immune response in germfree mice orally immunized with Vibrio cholerae.用霍乱弧菌经口免疫无菌小鼠后的免疫反应。
Keio J Med. 1972 Jun;21(2):113-26. doi: 10.2302/kjm.21.113.
10
Immunological conversion of Vibrio chorlerae in gnotobiotic mice.无菌小鼠中霍乱弧菌的免疫转化
Infect Immun. 1972 Nov;6(5):739-42. doi: 10.1128/iai.6.5.739-742.1972.
Zotero 插件